Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: a rapid diagnostic for three hemorrhagic fevers, a MERS vaccine to be tested in humans, and advances in R&D for HIV treatments
Kat Kelley, GHTC’s senior program assistant, highlights recent news in global health research, including the development of a paper-based rapid diagnostic test for Ebola, dengue, and yellow fever; an experimental vaccine for MERS that will be tested in humans later this year; and advancements made in HIV and hepatitis B treatments (8/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.